A Chloroacetamidine-Based Inactivator of Protein Arginine Methyltransferase 1: Design, Synthesis, and In Vitro and In Vivo Evaluation

被引：35

作者：

Obianyo, Obiamaka ^{[1
]}

Causey, Corey P. ^{[1
]}

Osborne, Tanesha C. ^{[1
]}

Jones, Justin E. ^{[1
]}

Lee, Young-Ho ^{[2
]}

Stallcup, Michael R. ^{[2
]}

Thompson, Paul R. ^{[1
]}

机构：

[1] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA

[2] Univ So Calif, Dept Biochem, Los Angeles, CA 90089 USA

来源：

CHEMBIOCHEM | 2010年 / 11卷 / 09期

关键词：

CI-amidine; enzymes; inhibitors; protein arginine methyltransferase; transcription; SUBSTRATE PEPTIDES; DEIMINASE; 4; METHYLATION; BINDING; PRMT1; PAD4;

D O I：

10.1002/cbic.201000209

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

(Chemical Equation Presented) Protein arginine methyltransferases (PRMTs) catalyze the post-translational methylation of arginine residues. PRMT1 is the predominant mammalian isozyme and is responsible for generating the majority of the asymmetrically dimethylated arginine found in vivo. Herein, we describe the most potent PRMT1 inhibitor, C21, described to date. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：1219 / 1223

页数：5

共 50 条

[1] A fluoroacetamidine-based inactivator of protein arginine deiminase 4: Design, synthesis, and in vitro and in vivo evaluation
Luo, Y
Knuckley, B
Lee, YH
Stallcup, MR
Thompson, PR
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (04) : 1092 - 1093
[2] Dynamics of human protein arginine methyltransferase 1 (PRMT1) in vivo
Herrmann, F
Lee, J
Bedford, MT
Fackelmayer, FO
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (45) : 38005 - 38010
[3] Arginine methyltransferase inhibitor-1 inhibits sarcoma viability in vitro and in vivo
Zhang, Baolai
Chen, Xue
Ge, Suyin
Peng, Caili
Zhang, Su
Chen, Xu
Liu, Tao
Zhang, Wenkai
[J]. ONCOLOGY LETTERS, 2018, 16 (02) : 2161 - 2166
[4] Design, Synthesis and Biological Evaluation of Carboxy Analogues of Arginine Methyltransferase Inhibitor 1 (AMI-1)
Castellano, Sabrina
Milite, Ciro
Ragno, Rino
Simeoni, Silvia
Mai, Antonello
Limongelli, Vittorio
Novellino, Ettore
Bauer, Ingo
Brosch, Gerald
Spannhoff, Astrid
Cheng, Donghang
Bedford, Mark T.
Sbardella, Gianluca
[J]. CHEMMEDCHEM, 2010, 5 (03) : 398 - 414
[5] Activity-Based Protein Profiling of Protein Arginine Methyltransferase 1
Obianyo, Obiamaka
Causey, Corey P.
Jones, Justin E.
Thompson, Paul R.
[J]. ACS CHEMICAL BIOLOGY, 2011, 6 (10) : 1127 - 1135
[6] In vitro and in vivo analysis of the major type I protein arginine methyltransferase from Trypanosoma brucei
Pelletier, M
Pasternack, DA
Read, LK
[J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2005, 144 (02) : 206 - 217
[7] Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-O-methyltransferase inhibitor
Rautio, Jarkko
Leppanen, Jukka
Lehtonen, Marko
Laine, Krista
Koskinen, Mikko
Pystynen, Jarmo
Savolainen, Jouko
Sairanen, Mikko
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2614 - 2616
[8] Protein Arginine Methyltransferase 1 and 8 Interact with FUS to Modify Its Sub-Cellular Distribution and Toxicity In Vitro and In Vivo
Scaramuzzino, Chiara
Monaghan, John
Milioto, Carmelo
Lanson, Nicholas A., Jr.
Maltare, Astha
Aggarwal, Tanya
Casci, Ian
Fackelmayer, Frank O.
Pennuto, Maria
Pandey, Udai Bhan
[J]. PLOS ONE, 2013, 8 (04):
[9] Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer in vitro and in vivo
Dong, Shu-Hong
Wang, Xing
Tian, San-Chun
Ma, Neng-Qian
Zhang, Xin-Yang
Liu, Yapeng
Zhang, Bao-Lai
Wu, Yong-Jie
[J]. PHARMAZIE, 2018, 73 (05): : 269 - 273
[10] Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation
Thuy Nguyen
Coover, Robert A.
Verghese, Jenson
Moran, Richard G.
Ellis, Keith C.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 462 - 467

← 1 2 3 4 5 →